Connection

Don Rockey to Liver Function Tests

Back to Details
This is a "connection" page, showing publications Don Rockey has written about Liver Function Tests.
Don Rockey
Connection Strength
3.871
Liver Function Tests
  1. The Utility of Liver Biopsy in the Evaluation of Liver Disease and Abnormal Liver Function Tests. Am J Clin Pathol. 2021 07 06; 156(2):259-267.
    View in: PubMed
    Score: 0.709
  2. The Association of Abnormal Liver Tests with Hepatitis C Testing in Primary Care. Am J Med. 2020 02; 133(2):214-221.e1.
    View in: PubMed
    Score: 0.620
  3. Evaluation of abnormal liver tests in the adult asymptomatic patient. Curr Opin Gastroenterol. 2018 07; 34(4):272-279.
    View in: PubMed
    Score: 0.576
  4. Assessing the Burden of Abnormal LFTs and the Role of the Electronic Health Record: A Retrospective Study. Am J Med Sci. 2018 Jun; 355(6):537-543.
    View in: PubMed
    Score: 0.560
  5. Liver test patterns in patients with acute calculous cholecystitis and/or choledocholithiasis. Aliment Pharmacol Ther. 2009 May 01; 29(9):1011-8.
    View in: PubMed
    Score: 0.305
  6. Ammonia Levels Do Not Guide Clinical Management of Patients With Hepatic Encephalopathy Caused by Cirrhosis. Am J Gastroenterol. 2020 05; 115(5):723-728.
    View in: PubMed
    Score: 0.163
  7. The utility of liver biopsy in 2020. Curr Opin Gastroenterol. 2020 05; 36(3):184-191.
    View in: PubMed
    Score: 0.163
  8. When Do Clinicians Follow-up Abnormal Liver Tests in Primary Care? Am J Med Sci. 2019 08; 358(2):127-133.
    View in: PubMed
    Score: 0.152
  9. Evaluation of liver test abnormalities in a patient-centered medical home: do liver test patterns matter? J Investig Med. 2018 12; 66(8):1118-1123.
    View in: PubMed
    Score: 0.144
  10. Liver biopsy. Hepatology. 2009 Mar; 49(3):1017-44.
    View in: PubMed
    Score: 0.075
  11. Regulation of peroxisome proliferator-activated receptor-gamma in liver fibrosis. Am J Physiol Gastrointest Liver Physiol. 2006 Nov; 291(5):G902-11.
    View in: PubMed
    Score: 0.063
  12. Noninvasive measures of liver fibrosis. Hepatology. 2006 Feb; 43(2 Suppl 1):S113-20.
    View in: PubMed
    Score: 0.061
  13. Antifibrotic therapy in chronic liver disease. Clin Gastroenterol Hepatol. 2005 Feb; 3(2):95-107.
    View in: PubMed
    Score: 0.057
  14. HLA-B*35:01 and Green Tea-Induced Liver Injury. Hepatology. 2021 06; 73(6):2484-2493.
    View in: PubMed
    Score: 0.044
  15. Hepatic fibrogenesis and hepatitis C. Semin Gastrointest Dis. 2000 Apr; 11(2):69-83.
    View in: PubMed
    Score: 0.041
  16. The Cost of Hepatitis C Testing Strategies in Primary Care Patients with Abnormal Transaminases. J Gen Intern Med. 2020 04; 35(4):1340-1342.
    View in: PubMed
    Score: 0.041
  17. Drug-Induced Liver Injury Caused by Kratom Use as an Alternative Pain Treatment Amid an Ongoing Opioid Epidemic. J Investig Med High Impact Case Rep. 2019 Jan-Dec; 7:2324709619826167.
    View in: PubMed
    Score: 0.037
  18. Associations of Race with Follow-up Patterns After Initial Abnormal Liver Tests in Primary Care. J Gen Intern Med. 2018 10; 33(10):1618-1620.
    View in: PubMed
    Score: 0.037
  19. Utility of 'liver function tests' in alcoholic patients. West J Med. 1992 Mar; 156(3):319-21.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.